Query: NC_008825:2525380 Methylibium petroleiphilum PM1, complete genome Lineage: Methylibium petroleiphilum; Methylibium; ; Burkholderiales; Proteobacteria; Bacteria General Information: Methylibium petroleiphilum strain PM1 (ATCC BAA-1232) was isolated in 1998 from the biofilter of a treatment plant in an oil refinery in Los Angeles, California, USA. Strain PM1 is capable of degrading aromatic compounds such as benzene, toluene and xylenes. Methyl tertiary-butyl ether-degrading bacterium. Methylibium petroleiphilum is a methylotroph (able to utilize reduced one-carbon compounds) able to degrade methyl tertiary-butyl ether (MTBE) under aerobic conditions. MTBE is a gasoline additive used as an oxygenate and to raise the octane number.
- Sequence; - BLASTN hit (Low score = Light, High score = Dark) - hypothetical protein; - cds: hover for description
General Information: This strain is a human clinical isolate from a human burn patient. It is infectious in mice, Caenorhabditis elegans, Drosophila melanogaster, and Arabidopsis thaliana. Opportunistic pathogen. Bacteria belonging to the Pseudomonas group are common inhabitants of soil and water and can also be found on the surfaces of plants and animals. Pseudomonas bacteria are found in nature in a biofilm or in planktonic form. Pseudomonas bacteria are renowned for their metabolic versatility as they can grow under a variety of growth conditions and do not need any organic growth factors. This organism is an opportunistic human pathogen. While it rarely infects healthy individuals, immunocompromised patients, like burn victims, AIDS-, cancer- or cystic fibrosis-patients are at increased risk for infection with this environmentally versatile bacteria. It is an important soil bacterium with a complex metabolism capable of degrading polycyclic aromatic hydrocarbons, and producing interesting, biologically active secondary metabolites including quinolones, rhamnolipids, lectins, hydrogen cyanide, and phenazines. Production of these products is likely controlled by complex regulatory networks making Pseudomonas aeruginosa adaptable both to free-living and pathogenic lifestyles. The bacterium is naturally resistant to many antibiotics and disinfectants, which makes it a difficult pathogen to treat.